|
TMEM209 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.120500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.749700E-02 |
| Normal-vs-Stage2 |
1.971820E-01 |
| Normal-vs-Stage3 |
9.117900E-02 |
| Normal-vs-Stage4 |
6.510400E-02 |
| Stage1-vs-Stage2 |
3.063200E-01 |
| Stage1-vs-Stage3 |
4.080000E-01 |
| Stage1-vs-Stage4 |
3.394400E-01 |
| Stage2-vs-Stage3 |
4.617000E-01 |
| Stage2-vs-Stage4 |
5.923000E-01 |
| Stage3-vs-Stage4 |
7.078800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.023500E-03 |
| Normal-vs-AfricanAmerican |
1.331360E-01 |
| Normal-vs-Asian |
6.994000E-01 |
| Caucasian-vs-AfricanAmerican |
6.296200E-01 |
| Caucasian-vs-Asian |
8.198200E-01 |
| AfricanAmerican-vs-Asian |
7.789400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.799900E-02 |
| Normal-vs-Female |
6.221600E-03 |
| Male-vs-Female |
5.418500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.552200E-01 |
| Normal-vs-Extreme_Weight |
1.457370E-01 |
| Normal-vs-Obese |
3.037600E-02 |
| Normal-vs-Extreme_Obese |
5.899800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.948800E-01 |
| Normal_Weight-vs-Obese |
3.021200E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.610400E-01 |
| Extreme_Weight-vs-Obese |
1.919820E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.118000E-01 |
| Obese-vs-Extreme_Obese |
6.114100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.190250E-02 |
| Normal-vs-Age(41-60Yrs) |
2.974200E-04 |
| Normal-vs-Age(61-80Yrs) |
2.321800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.386000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.934600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.220100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.701400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.163770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.140200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.932800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.137100E-03 |
| Normal-VS-Type2 PRCC |
6.020600E-01 |
| Normal-VS-KIRP CIMP |
4.625700E-02 |
| Normal-VS-Unclassified PRCC |
1.420370E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.923800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.629600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.543200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.399500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.780400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.106830E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.060200E-01 |
| Normal-vs-N1 |
4.609800E-02 |
| Normal-vs-N2 |
2.804400E-02 |
| N0-vs-N1 |
5.755900E-02 |
| N0-vs-N2 |
3.767600E-01 |
| N1-vs-N2 |
9.263800E-01 |
|
|
